Group 1 - Yisheng Pharmaceutical's stock price fell by 5.12% on November 21, closing at 7.79 yuan per share, with a trading volume of 51.63 million yuan and a turnover rate of 2.79%, resulting in a total market capitalization of 2.578 billion yuan [1] - The stock has experienced a continuous decline for four consecutive days, with a cumulative drop of 4.98% during this period [1] - Yisheng Pharmaceutical, established on June 11, 1997, and listed on March 18, 2011, specializes in the research, production, and sales of traditional Chinese medicine, with its main revenue sources being capsule products (47.89%), injection products (30.94%), cosmetics (7.39%), ginseng products (6.89%), other products (6.59%), and bee products (0.31%) [1] Group 2 - Among the top ten circulating shareholders of Yisheng Pharmaceutical, a fund under Nuoan Fund, specifically Nuoan Multi-Strategy Mixed A (320016), entered the top ten in the third quarter, holding 1.9863 million shares, which accounts for 0.86% of the circulating shares [2] - The estimated floating loss for the fund today is approximately 834,200 yuan, with a total floating loss of 854,100 yuan during the four-day decline [2] - Nuoan Multi-Strategy Mixed A was established on August 9, 2011, with a current scale of 1.855 billion yuan, achieving a year-to-date return of 73.37% and ranking 205 out of 8,136 in its category [2]

Core Viewpoint - Yisheng Pharmaceutical's stock has experienced fluctuations, with a year-to-date increase of 23.66% but a recent decline of 2.12% over the past five trading days [1][2]. Financial Performance - For the period from January to September 2025, Yisheng Pharmaceutical reported a revenue of 476 million yuan, representing a year-on-year decrease of 5.81%. The net profit attributable to shareholders was 24.13 million yuan, down 32.72% compared to the previous year [2]. - Cumulative cash dividends since the company's A-share listing amount to 213 million yuan, with 99.29 million yuan distributed over the past three years [3]. Shareholder Information - As of November 10, 2025, the number of shareholders for Yisheng Pharmaceutical was 19,700, a decrease of 1.92% from the previous period. The average number of circulating shares per person increased by 1.96% to 11,740 shares [2]. - Notably, as of September 30, 2025, the eighth largest circulating shareholder is the Nuoan Multi-Strategy Mixed A fund, which holds 1.9863 million shares as a new shareholder [3]. Stock Performance - As of November 19, Yisheng Pharmaceutical's stock price was 8.31 yuan per share, with a market capitalization of 2.75 billion yuan. The stock saw a trading volume of 12.1 million yuan and a turnover rate of 0.62% [1].